Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | MMP9 | P14780 | 3/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | CPT1A | P50416 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | MMP2 | P08253 | 2/20 | 0.30 |
| ▸ | MMP8 | P22894 | 2/20 | 0.30 |
| ▸ | MMP13 | P45452 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Allobarbital SCHEMBL11484021 | 0.98 | LMNA (0.46) | LMNAMMP9TP53GAAHPGD | |
| Allobarbital SCHEMBL10817112 | 0.89 | MMP9 (0.41) | LMNAMMP9TP53 | |
| Allobarbital SCHEMBL1887977 | 0.89 | LMNA (0.50) | LMNAMMP9TP53CPT1AALDH1A1 | |
| Etallobarbital SCHEMBL713588 | 0.87 | LMNA (0.64) | LMNAMMP9TP53CPT1AALDH1A1 | |
| SCHEMBL2048015 | 0.86 | MMP9 (0.42) | LMNAMMP9TP53 | |
| SCHEMBL2048014 | 0.86 | MMP9 (0.42) | LMNAMMP9TP53 | |
| Allobarbital SCHEMBL7871535 | 0.84 | MMP9 (0.38) | LMNAMMP9TP53 | |
| SCHEMBL7646655 | 0.84 | MMP9 (0.41) | LMNAMMP9TP53 | |
| SCHEMBL5065701 | 0.83 | ALDH1A1 (0.43) | LMNAMMP9CPT1AALDH1A1 | |
| SCHEMBL2051800 | 0.82 | MMP9 (0.36) | MMP9CPT1AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4735 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250081863-A1 | STRUCTURE TO REGULATE MULTI-FILAMENT FORMATION ON MEMORY STRUCTURE | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2025-03-06 | — | — | US | claimed |
| CN-115148900-B | Resistance-switching memory device and method for forming a resistance-switching memory device | 昕原半导体(上海)有限公司 | 2025-02-21 | — | — | CN | claimed |
| US-12161695-B2 | GABA A receptor agonists for treatment of disorders influenced by dysfunction BETA cells | DIAMYD MEDICAL AB (SE) | 2024-12-10 | — | — | US | claimed |
| US-12133922-B2 | Abuse resistant capsule | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2024-11-05 | — | — | US | claimed |
| US-12075712-B2 | Resistive switching memory devices and method(s) for forming the resistive switching memory devices | Crossbar, Inc. (US) | 2024-08-27 | — | — | US | claimed |
| WO-2024150170-A1 | PIROMELATINE FOR TREATING PARASOMNIAS ASSOCIATED WITH LOSS OF REM SLEEP ATONIA | NEURIM PHARMACEUTICALS (1991) LTD. (IL) | 2024-07-18 | — | — | WO | claimed |
| US-20240238250-A1 | METHOD OF USING PIROMELATINE FOR TREATING PARASOMNIAS ASSOCIATED WITH LOSS OF REM SLEEP ATONIA | NEURIM PHARMACEUTICALS (1991) LTD. (IL) | 2024-07-18 | — | — | US | claimed |
| US-11839615-B2 | Compounds and methods for treating addiction and related disorders | ASTROCYTE PHARMACEUTICALS, INC. (US) | 2023-12-12 | — | — | US | claimed |
| US-20220362160-A1 | ABUSE RESISTANT CAPSULE | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2022-11-17 | — | — | US | claimed |
| US-11464747-B2 | Abuse resistant capsule | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2022-10-11 | — | — | US | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| EP-0900086-A4 | ENHANCEMENT OF SLEEP WITH A GROWTH HORMONE SECRETAGOGUE | MERCK & CO INC (US) | 2000-01-12 | — | — | EP | claimed |
| EP-0900086-A1 | ENHANCEMENT OF SLEEP WITH A GROWTH HORMONE SECRETAGOGUE | Merck & Co., Inc. (US) | 1999-03-10 | — | — | EP | claimed |
| WO-1997041879-A1 | ENHANCEMENT OF SLEEP WITH A GROWTH HORMONE SECRETAGOGUE | MERCK & CO., INC. (US) | 1997-11-13 | — | — | WO | claimed |
| US-4690824-A | Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range | REDI-ROWELL, INC. (US) | 1987-09-01 | — | — | US | claimed |
| EP-0090966-B1 | PROCESS FOR ANTIGEN DETERMINATION | AMERICAN HOSPITAL SUPPLY CORPORATION (US) | 1985-12-18 | — | — | EP | claimed |
| US-4458044-A | PREVENTION OF FORMATION OF WATER TREES | SIEMENS AKTIENGESELLSCHAFT (DE) | 1984-07-03 | — | — | US | claimed |
| US-4382983-A | PARTIALLY HYDROLYZED SILOXANE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1983-05-10 | — | — | US | claimed |
| US-4284707-A | Photocurable light-sensitive composition | SOMAR MANUFACTURING CO., LTD. (JP) | 1981-08-18 | — | — | US | claimed |
| US-4126684-A | 4-AMINO-3-P-HALOPHENYLBUTYRIC ACIDS AND THEIR DERIVATIVES USED IN THE CONTROL OF NARCOTIC ABUSE | CIBA-GEIGY CORPORATION (US) | 1978-11-21 | — | — | US | claimed |